Geode Capital Management, LLC Bellerophon Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.9 - $7.89 $28,314 - $248,219	31,460 Added 49.01%	95,656 $754,000
Q4 2022 Feb 13, 2023	SELL	$0.67 - $1.2 $106 - $190	-159 Reduced 0.25%	64,196 $57,000
Q2 2022 Aug 12, 2022	BUY	$0.85 - $2.36 $5,111 - $14,193	6,014 Added 10.31%	64,355 $79,000
Q1 2022 May 13, 2022	SELL	$1.82 - $3.24 $16 - $29	-9 Reduced 0.02%	58,341 $137,000
Q4 2021 Feb 11, 2022	SELL	$2.36 - $4.05 $59 - $101	-25 Reduced 0.04%	58,350 $180,000
Q3 2021 Nov 12, 2021	SELL	$3.75 - $4.86 $18 - $24	-5 Reduced 0.01%	58,375 $237,000
Q2 2021 Aug 13, 2021	SELL	$3.83 - $5.65 $19,410 - $28,634	-5,068 Reduced 7.99%	58,380 $282,000
Q1 2021 May 12, 2021	BUY	$5.07 - $8.27 $2,185 - $3,564	431 Added 0.68%	63,448 $329,000
Q4 2020 Feb 12, 2021	BUY	$6.12 - $10.37 $9,632 - $16,322	1,574 Added 2.56%	63,017 $420,000
Q3 2020 Nov 13, 2020	BUY	$9.27 - $13.79 $168,621 - $250,840	18,190 Added 42.05%	61,443 $625,000
Q2 2020 Aug 13, 2020	BUY	$9.43 - $20.28 $281,768 - $605,966	29,880 Added 223.44%	43,253 $542,000
Q1 2020 May 14, 2020	BUY	$3.39 - $18.0 $45,334 - $240,714	13,373 New	13,373 $146,000

44K

Ticker BLPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,545,450
Market Cap $382K
Description
Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.